explore
Previous article:
FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article: Biogen Alzheimer’s drug launch off to slow start
Next article: Biogen Alzheimer’s drug launch off to slow start
focus
entertainment
-
Three trends to watch in biotech in 2024
2025-08-28 12:54 -
A disappointing year of Humira biosimilars
2025-08-28 12:28 -
What should King Charles tell the public about his cancer?
2025-08-28 11:48 -
Virtual care provider acquires bankrupt Pear's prescription apps
2025-08-28 11:27 -
Medicare Advantage beneficiaries sue Humana over algorithm use
2025-08-28 11:06 -
In Spain, a hospital brews its own CAR
2025-08-28 10:27